As of 2025-07-14, the ROE (Return on Equity) of Angion Biomedica Corp (ANGN) is -88.7%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
Date | Value |
---|---|
2022-12-31 | -88.7% |
2021-12-31 | -67% |
2020-12-31 | 88.6% |
2019-12-31 | 218.7% |
2018-12-31 | -105.9% |
- | |
- | |
- | |
- | |
- |